EUVIMEDOtkrijte EUVIMED
Open access · CC BY-NC-ND 4.0

Loss of viral genome with altered immune microenvironment during tumour progression of Epstein‐Barr virus ‐associated gastric carcinoma

Atsushi Kondo, Aya Shinozaki-Ushiku iD, Hirofumi Rokutan iD, Akiko Kunita, Masako Ikemura, Hiroharu Yamashita, Yasuyuki Seto, Genta Nagae, Kenji Tatsuno, Hiroyuki Aburatani, Daizo Koinuma, Tetsuo Ushiku

The Journal of Pathology · 2023

DOI: 10.1002/path.6067 ↗

At a glance

Journal article in The Journal of Pathology, 2023. Written by Atsushi Kondo and 11 co-authors. Institution: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Major MEDLINE topics: Epstein-Barr Virus Infections, Stomach Neoplasms, Carcinoma. Cited 7 times so far (Crossref); 18 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Japan Agency for Medical Research and Development.

SažetakSubjectsBibliografski podaciCiteRelated studies

Abstract (original language)

Epstein‐Barr virus (EBV) is one of the major drivers of gastric carcinogenesis. EBV infection is established before tumour initiation and is generally maintained throughout tumour development; however, the significance of EBV in tumour maintenance and progression remains to be elucidated. Here, we report eight cases of EBV‐associated gastric carcinoma (EBVaGC) with intratumoural heterogenous expression of EBV‐encoded small RNA ( EBER ), a highly expressed latent gene of EBV, and demonstrate clinicopathological characteristics of these rare cases. By performing detailed histological assessment of EBER ‐positive and ‐negative components of each case, detection of EBV genome in tumour cells by fluorescence in situ hybridisation, TP73 methylation analysis, whole exome sequencing, and targeted gene panel sequencing, we identified tumours in two patients to be collision tumours of different origins. In the other six patients, some genetic/epigenetic alterations were shared between EBER ‐positive and ‐negative components, suggesting that EBV was eliminated from tumour cells during progression. Interestingly, in both tumour types, programmed death ligand 1 and intratumoural infiltration of CD8+ T lymphocytes were lower in EBER ‐negative than in EBER ‐positive components, suggesting an immunogenic role of EBV. To the best of our knowledge, this study is the first to demonstrate the detailed histological features and genetic/epigenetic alterations in EBVaGC with heterogenous EBER expression; the loss of EBV may benefit tumour progression and immune evasion and might be clinically important for selecting treatment strategies for such cancers. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Epstein-Barr Virus InfectionsStomach NeoplasmsCarcinomaHumansHerpesvirus 4, HumanGenome, ViralRNA, ViralTumor Microenvironment

Author keywords

EBEREpstein-Barr virusPD-L1hit-and-run

Substances

RNA, Viral

Authors and institutions

  • Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Division of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Next-Generation Precision Medicine Development Laboratory, and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.
  • Genome Science and Medicine Laboratory, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.

ORCID profiles: Aya Shinozaki-Ushiku, Hirofumi Rokutan

Funding

  • Japan Agency for Medical Research and Development

Cite

APA

Kondo, A., Shinozaki-Ushiku, A., Rokutan, H., Kunita, A., Ikemura, M., Yamashita, H., Seto, Y., Nagae, G., Tatsuno, K., Aburatani, H., Koinuma, D., & Ushiku, T. (2023). Loss of viral genome with altered immune microenvironment during tumour progression of Epstein‐Barr virus ‐associated gastric carcinoma. The Journal of Pathology. https://doi.org/10.1002/path.6067

Vancouver

Kondo A, Shinozaki-Ushiku A, Rokutan H, Kunita A, Ikemura M, Yamashita H, et al. Loss of viral genome with altered immune microenvironment during tumour progression of Epstein‐Barr virus ‐associated gastric carcinoma. The Journal of Pathology. 2023. doi:10.1002/path.6067

BibTeX
@article{Kondo2023,
  author = {Kondo, Atsushi and Shinozaki-Ushiku, Aya and Rokutan, Hirofumi and Kunita, Akiko and Ikemura, Masako and Yamashita, Hiroharu and Seto, Yasuyuki and Nagae, Genta and Tatsuno, Kenji and Aburatani, Hiroyuki and Koinuma, Daizo and Ushiku, Tetsuo},
  title = {Loss of viral genome with altered immune microenvironment during tumour progression of Epstein‐Barr virus ‐associated gastric carcinoma},
  journal = {The Journal of Pathology},
  year = {2023},
  doi = {10.1002/path.6067}
}
Start for free →